PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: Kemin Industries, Inc.

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Kemin Announces New Employees for Pet Food Division - Kemin Industries announces the addition of two employees to Kemin Nutrisurance, the company’s pet food division
Kemin Announces New Employees for Pet Food Division

 

NewswireToday - /newswire/ - Des Moines, IA, United States, 2010/09/03 - Kemin Industries announces the addition of two employees to Kemin Nutrisurance, the company’s pet food division.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Mitch Poss, Ph.D., has joined as director of research and development and Radek Nigrin has joined as senior commercial manager.

Poss will initiate and oversee the innovation of new products, an integral part of Kemin´s vision and strategy. He has over 18 years of experience in managing research teams and developing new products.

Prior to joining Kemin, Poss was the director of chemistry for Nanosphere, Inc., a nanotechnology-based, in-vitro diagnostics company. He has also held various positions at Baxter Healthcare, including global research and development director and research scientist.

Nigrin will be responsible for managing the sales team and commercial business in Europe. He most recently worked as the senior marketing manager for Kemin AgriFoods Europe. Prior to that, he was the area manager in the Czech Republic, Slovak Republic and Baltic States.

“Mitch was the clear choice for our new R&D director because of his extensive experience and knowledge in the field,” said Giuseppe Abrate, president of Kemin Nutrisurance. “Under his guidance, we expect that our R&D team will continue in its growth and commitment to innovation. We are also excited to welcome Radek to Kemin Nutrisurance. His previous sales and marketing experience within Kemin will help ensure success for the pet food division’s marketing and commercial efforts.”

Poss received a Ph.D. in chemistry from the University of Utah and a Bachelor of Science in chemistry from Fort Lewis College in Colorado.

Nigrin received a Master of Science in animal nutrition from the University of South Bohemia in the Czech Republic.

Kemin® – Inspired Molecular Solutions™
Founded in 1961, the Kemin group of companies (kemin.com) provides health and nutritional solutions to the agrifood, food ingredient, pet food, human health and pharmaceutical industries. Kemin operates in more than 60 countries with manufacturing facilities in Belgium, Brazil, China, India, Singapore, South Africa, Thailand and the United States.

Kemin Nutrisurance is exclusively focused on providing innovative solutions to the global pet food and pet supplement industry. A trusted supplier of superior palatant and antioxidant products, Kemin understands how a product works at the molecular level and uses superior chemistry to uncover the best ways to deliver nutritional solutions to pets with maximum efficacy.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Written by / Agency / Source: Kemin Industries, Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick Newswire Today Visibility Checker

 

Distribution / Indexing: [+] / [Company listed above is a registered member of our network. Content made possible by PRZOOM / PRTODAY indexing services]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Kemin Announces New Employees for Pet Food Division

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
 
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

|
Publisher Contact: Kristen Kroll / Erin Hockman 
515-559-5408 / 515-559-5349 kristen.kroll[.]kemin.com / erin.hockman[.]kemin.com
 
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any Kemin Industries, Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From Kemin Industries, Inc. / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

First European Patients Treated with DC Bead LUMI™ Radiopaque Drug-Eluting Beads
FDA Approves Genentech’s Lucentis (Ranibizumab Injection) for Diabetic Retinopathy
Biopharmaceutical Analytical Instrumentation Market Garners Strong Opportunities from Double-digit Growth in Biosimilars Finds Frost & Sullivan
BD Completes Acquisition of Caesarea Medical Electronics
MDxHealth and Ghent University Ink Licensing and Collaboration Agreements to Develop Cancer Biomarker Visualization Technology
Ipsen Completes Acquisition of ONIVYDE® (irinotecan liposome injection) and Additional Oncology Assets from Merrimack Pharmaceuticals
FDA Grants Breakthrough Therapy Designation for Rituxan® (Rituximab) in Pemphigus Vulgaris
MDxHealth Signs Agreement with Lab21 to Make SelectMDx Liquid Biopsy Test Available in the United Kingdom
Greenphire Drives Global Site Adoption of Clinical Trial Payment Solutions
Ipsen Announces MHRA Approval of New Indication for Decapeptyl® for the Treatment of Pre-menopausal Women with Early Stage Breast Cancer
SelectMDx Chosen by Michigan Medicine as Pre-biopsy Diagnostic Tool in Groundbreaking US Prostate Cancer Risk Clinic
BTG Announces CE Mark Certification for DC Bead LUMI™ - The First Commercially Available Radiopaque Drug-Eluting Bead
Sartorius to Acquire Real-time Live-cell Analysis Pioneer and Leader Essen BioScience
Pyxis™ ES System to Help U.S. Department of Defense Advance Medication Safety and Patient Care
BTG Receives U.S. FDA 510(k) Clearance for EKOS® Control Unit 4.0

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  NAKIVO, Inc.

Visit  BizJobs.com





 
  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (usatoday.com)